Valsartan and Oseltamivir phosphate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Valsartan (valsartan) and Oseltamivir phosphate (oseltamivir phosphate). Common drug interactions include chronic kidney disease among females and influenza like illness among males.

The phase IV clinical study analyzes what interactions people have when they take Valsartan and Oseltamivir phosphate. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Valsartan?

Valsartan has active ingredients of valsartan. It is often used in high blood pressure. eHealthMe is studying from 63,805 Valsartan users. Check the latest studies of Valsartan.

What is Oseltamivir phosphate?

Oseltamivir phosphate has active ingredients of oseltamivir phosphate. eHealthMe is studying from 1,825 Oseltamivir phosphate users. Check the latest studies of Oseltamivir phosphate.



On Jul, 10, 2026

19 people who take Valsartan and Oseltamivir phosphate together, and have interactions are studied.

Valsartan and Oseltamivir phosphate drug interactions.

What are the common drug interactions of Valsartan and Oseltamivir Phosphate, by gender? *:

female:

  1. Chronic kidney disease
  2. Diarrhoea
  3. Ischaemic cerebral infarction (ischemic stroke resulting from a disturbance in the blood vessels supplying blood to the brain)
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Vomiting
  6. Erythema (redness of the skin)
  7. Pruritus (severe itching of the skin)
  8. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  9. Anxiety
  10. Asthenia (weakness)

male:

  1. Influenza like illness
  2. Pyrexia (fever)
  3. Febrile neutropenia (fever with reduced white blood cells)
  4. Flatulence (flatus expelled through the anus)
  5. Hypovolaemic shock (shock caused by severe blood or fluid loss)
  6. Influenza
  7. Nausea (feeling of having an urge to vomit)
  8. Palpitations (feelings or sensations that your heart is pounding or racing)
  9. Pneumonia
  10. Urinary tract infection

What are the common drug interactions of Valsartan and Oseltamivir Phosphate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Influenza like illness
  2. Pyrexia (fever)
  3. Renal impairment (severely reduced kidney function)
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Drug ineffective
  6. Influenza

50-59:

  1. Chronic kidney disease
  2. Asthenia (weakness)
  3. Feeling cold
  4. Headache (pain in head)
  5. Hypovolaemic shock (shock caused by severe blood or fluid loss)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Nausea (feeling of having an urge to vomit)

60+:

  1. Chronic kidney disease
  2. Diarrhoea
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Emotional distress
  5. Febrile neutropenia (fever with reduced white blood cells)
  6. Hot flush (sudden feelings of heat)
  7. Pain
  8. Pain in jaw
  9. Palpitations (feelings or sensations that your heart is pounding or racing)
  10. Rash

What are the existing conditions these people have? *

  1. The Flu (the flu is caused by an influenza virus): 7 people, 36.84%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 26.32%
  3. High Blood Cholesterol: 4 people, 21.05%
  4. Pain: 4 people, 21.05%
  5. Infection: 4 people, 21.05%
  6. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 15.79%
  7. Cough: 3 people, 15.79%
  8. Depression: 3 people, 15.79%
  9. Skin Infection: 3 people, 15.79%
  10. Fungal Infection: 3 people, 15.79%

* Approximation only. Some reports may have incomplete information.

Do you take Valsartan and Oseltamivir phosphate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Valsartan and Oseltamivir phosphate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Valsartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Oseltamivir phosphate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valsartan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oseltamivir phosphate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on valsartan and oseltamivir phosphate (the active ingredients of Valsartan and Oseltamivir phosphate, respectively), and Valsartan and Oseltamivir phosphate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: